Wows Rome audience with live study setup and launch...
WAYLAND, Mass., March 20 /PRNewswire/ -- Tourtellotte Solutions, a global leader in bio-pharmaceutical clinical trials software, announces the launch of its Trident IWR(TM) next-generation IWR/IVRS platform for phase II-IV studies. Trident's unique parameter driven + custom pluggable design leaps ahead of legacy IVRS technologies and promises to deliver a new era of needed scalability, productivity, and ease-of-use to the straining global clinical IVRS market.
Tourtellotte representatives demonstrated the next-generation Trident IWR, fully integrated with the tcVisualize(TM) clinical supply simulator, to an appreciative audience at the VIB Clinical Supply Europe conference in Rome, Italy on February 25th, 2008.
Clinical IVRS (or IWR) systems are the source and driver of patient randomization, drug dispensing, and trial supply logistics, and as such are critical to the multi-center clinical trials that they support. Having grown up from older telephony-based technology and designs, however, current IVRS platforms are difficult to scale, and time consuming to set up. Some estimates put the industry standard programming time for a new clinical trial in IVRS to be 8-12 weeks, with commensurate cost, risk and technical design and validation overhead.
A parameter driven IWR such as Trident can eliminate this lead-time and a host of other difficulties due to its parameterized design, coupled with automatic 2-way integration with trial simulators such as tcVisualize. The Tourtellotte team in Rome demonstrated this concept by soliciting a live study design from the audience, then setting up and simulating the study in tcVisualize, and exporting the study to Trident. After switching on the study in Trident IWR, the TS team then acted as a clinical site to screen, randomize, and dose subjects, and then brought the data back into tcVisualize to show end to end study design, launch, execution and review -- typically a 12 week process -- in less than 30 minutes.
"I believe that the time for next-generation IWR has come", said Ed Tourtellotte, president & CEO of Tourtellotte Solutions. "There is a lot of pressure on the IVRS market right now -- demand is growing faster than legacy technologies can scale to meet it. Service outages are in the press. Both vendors and bio-pharmaceuticals are starting to realize that a more modern, more scalable technology is badly needed."
In 2001, Tourtellotte Solutions pioneered the first major parameter-driven IVRS (and also the world's first IWR) for a global pharmaceutical company. The success of this model over time, coupled with pluggable customization modules and other Tourtellotte innovations, has proven the value and utility of next-generation IWR concepts. More recently, Tourtellotte Solutions has made waves with its groundbreaking and now market-leading tcVisualize clinical supply simulator, and is well positioned to deliver integrated next-generation IWR / IVRS technology to the bio-pharmaceutical industry in 2008.
For more information on Tourtellotte Solutions and the Trident IWR product, please visit http://www.TridentIWR.com. For information on the tcVisualize product, please visit http://www.tcVisualize.com.
About Tourtellotte Solutions
Tourtellotte Solutions is a global leader in software and services for the bio-pharmaceutical industry. In addition to Trident IWR, Tourtellotte Solutions' offers tcVisualize, a groundbreaking clinical supply chain modeling and forecasting used by many leading bio-pharmaceutical companies, and the Fusion DMC(TM) Document Management, Workflow and Collaboration Platform. Tourtellotte also provides custom application development and consulting services. Tourtellotte Solutions is a privately held company headquartered in Wayland, Massachusetts.
For more information on Tourtellotte Solutions or its products, please
call Paul Colburn at 1.860.833.1710, or visit
Contact: Paul Colburn
|SOURCE Tourtellotte Solutions|
Copyright©2008 PR Newswire.
All rights reserved